Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)

Minot Light Capital, an investment management firm, recently released its fourth-quarter 2024 investor letter. A copy of the same can be downloaded here. This is the first partner update of Minot Light Capital after the fund’s launch on October 1, 2024. The partnership gained 6.9% gross/5.2% net in the quarter versus 2.4% for the S&P 500 total return index and 0.3% for the Russell 2000. The firm is pleased to see positive relative performance of the fund in both up and down markets over the...